Cipher Pharmaceuticals Inc faces a challenging market as it navigates through recent performance trends and analyst expectations.
This week, Cipher Pharmaceuticals Inc (CPH.TO) has seen its stock price fluctuate amid a backdrop of broader market dynamics and company-specific developments. With a slight decline over the past week, investors are looking closely at the company's recent financial disclosures and performance metrics.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$358.35M
P/E
9.0x
52W high
$20.56
52W low
$12.48
1W change
-1.47%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 41.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.95
+41.5% Upside
Current Price
C$14.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.4%
Annualized
90-Day Vol
50.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.79
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$13.29 | C$10.31 โ C$17.11 |
| 60 trading days | C$12.52 | C$8.75 โ C$17.91 |
| 90 trading days | C$11.79 | C$7.61 โ C$18.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Cipher Pharmaceuticals is currently trading below its moving averages, indicating potential challenges ahead, even as analysts remain optimistic about its future growth.
Cipher Pharmaceuticals Inc's stock price closed at C$14.16.
Trading volume was 1.38 times the 20-day average, suggesting heightened investor interest despite recent price declines.
Bull case
Despite the recent price drop, Cipher's strong profit margins and solid return on equity indicate that the company is well-positioned for future growth. Analysts maintain a positive outlook, which supports the belief that Cipher can rebound and thrive in the coming months.
Bear case
The stock's performance has lagged behind its moving averages, and the recent decline in share price raises concerns about potential underlying challenges. Investors should keep these factors in mind as they evaluate their positions.
Recent Price Action
This week, Cipher Pharmaceuticals Inc (CPH.TO) closed at C$14.16, marking a 1D change of 0.00% and a decline of 1.47% over the past week. Year-to-date, the stock has decreased by 5.37%, reflecting ongoing challenges in its market environment.
Advertisement
Company News and Earnings Report
On August 11, 2026, Cipher Pharmaceuticals reported its second-quarter results, which may have influenced investor sentiment. While specific details from the earnings report were not provided, such reports typically shed light on revenue growth, profit margins, and future guidance, all of which are crucial for assessing the company's performance.
Technical Picture
From a technical perspective, Cipher's stock is currently below its 50-day moving average of C$16.28 and its 200-day moving average of C$15.97, indicating a bearish trend. The stock has traded within a 52-week range of C$12.48 to C$20.56, currently sitting at approximately 21% of that range. With a beta of 0.46, the stock is less volatile than the broader market, but recent volume trends show a notable increase, with the latest volume at 29,275 shares compared to a 20-day average of 62,080 shares, suggesting increased investor interest.
Insider Activity
Currently, there are no reported insider trades for Cipher Pharmaceuticals, which can often provide insights into management's confidence in the company's future prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
